Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


New windows open for immunotherapy in lung cancer

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Nature 558, 376-377 (2018)



  1. NSCLC Meta-Analyses Collaborative Group. J. Clin. Oncol. 26, 4617–4625 (2008).

    PubMed  Article  Google Scholar 

  2. Forde, P. M. et al. N. Engl. J. Med. (2018).

    PubMed  Article  Google Scholar 

  3. Hellmann, M. D. et al. N. Engl. J. Med. (2018).

    Article  Google Scholar 

  4. Hoos, A. Nature Rev. Drug Discov. 15, 235–247 (2016).

    PubMed  Article  Google Scholar 

  5. Bianco, A., Malapelle, U., Rocco, D., Perrotta, F. & Mazzarella, G. Curr. Opin. Pharmacol. 40, 46–50 (2018).

    PubMed  Article  Google Scholar 

  6. Reck, M. et al. N. Engl. J. Med. 375, 1823–1833 (2016).

    PubMed  Article  Google Scholar 

  7. Brahmer, J. et al. N. Engl. J. Med. 373, 123–135 (2015).

    PubMed  Article  Google Scholar 

  8. Hellmann, M. D. et al. Cancer Cell (2018).

    Article  Google Scholar 

  9. Gandhi, L. et al. N. Engl. J. Med. (2018).

    Article  Google Scholar 

  10. Reck, M. et al. Ann. Oncol. 28 (Suppl. 11), xi31 (2017).

    Article  Google Scholar 

  11. Ferrara, R. et al. J. Thorac. Oncol. 12 (Suppl. 2), S1843–S1844 (2017).

    Article  Google Scholar 

  12. NICE. Nivolumab in combination with ipilimumab for treating advanced melanoma. Available at (2016).

Download references


Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links